Xin Lang Cai Jing·2026-01-12 01:45Company Overview - Spring Medical is primarily engaged in the research, production, and sales of implantable orthopedic medical devices, with a focus on joint prosthetics and spinal implants [1][2] - The company was established on February 12, 1998, and went public on December 30, 2021 [1] - Its main products include hip, knee, shoulder, and elbow joint prosthetics, as well as a full range of spinal fixation systems [1] Financial Performance - For the period from January to September 2025, Spring Medical achieved a revenue of 756 million yuan, representing a year-on-year growth of 48.75% [2] - The net profit attributable to the parent company for the same period was 192 million yuan, showing a significant year-on-year increase of 213.21% [2] - Since its A-share listing, the company has distributed a total of 440 million yuan in dividends, with 390 million yuan distributed over the past three years [3] Stock Performance - As of January 12, 2025, Spring Medical's stock price was 24.45 yuan per share, with a year-to-date increase of 7.85% [1] - The stock experienced a slight decline of 2.16% on the same day, with a trading volume of 871.39 million yuan and a turnover rate of 0.12% [1] - The company has seen a net inflow of 555,100 yuan from main funds, with large orders accounting for 16.81% of total purchases [1] Shareholder Information - As of September 30, 2025, the number of shareholders increased by 4.12% to 6,164, while the average circulating shares per person decreased by 3.95% to 46,906 shares [2] - Notable new shareholders include Hong Kong Central Clearing Limited and China Europe Economic Growth Mixed A Fund, which are now among the top ten circulating shareholders [3]